Heparin Global Market Size is Expected to Grow to $11.38 Billion at a CAGR of 5.5% By 2027 | Baxter, B. Braun Medical Inc., Pfizer Inc., Sanofi, Opocrin S.p.A., Aspen Holdings
Heparin Global Market Size is Expected to Grow to $11.38 Billion at a CAGR of 5.5% By 2027 | Baxter, B. Braun openPR
sdgtalks
Heparin Market
The Business Research Company’s Global Market Reports
The Business Research Company’s global market reports have been updated with the latest market sizing information for the year 2023 and forecasted to 2032.
Sustainable Development Goals (SDGs)
- No Poverty
- Good Health and Well-being
- Industry, Innovation, and Infrastructure
- Reduced Inequalities
- Sustainable Cities and Communities
- Responsible Consumption and Production
The Heparin Global Market Report 2023
The Business Research Company’s Heparin Global Market Report 2023 identifies that the increasing prevalence of chronic diseases is significantly driving the growth of the heparin market. Chronic diseases refer to medical conditions that last more than one year and require constant medical attention or hospitalization for specialized treatment.
The global heparin market size grew from $8.67 billion in 2022 to $9.19 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The heparin market size is expected to grow to $11.38 billion in 2027 at a CAGR of 5.5%.
Download Free Sample of Heparin Market Report
Major players in the Heparin market are Baxter, B. Braun Medical Inc., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leo Pharma A/S, Pfizer Inc., Sanofi, Opocrin S.p.A., Aspen Holdings, GlaxoSmithKline plc, Hebei Changshan Biochemical Pharmaceutical Co, Bioiberica SAU, Shenzhen Hepalink, Rovi, Sandoz, Tiandong Pharma, and Viatris Inc.
Product advancement is a key trend gaining popularity in the heparin market. Key players and their research wings are increasingly focusing on developing an advanced and improved heparin or heparin prefilled syringe with precision and convenience to increase their business reach and presence across the globe.
Read More On The Global Heparin Market Report Here:
The Heparin Market Is Segmented
- By Product: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)
- By Source: Bovine, Porcine
- By Route of Administration: Intravenous, Subcutaneous
- By Application: Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Other Applications
- By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies
- By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Heparin market.
The Business Research Company’s “Global Heparin Market Report 2023” provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers, and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Heparin Market Report Here:
The Table Of Content For The Heparin Market Include:
- Executive Summary
- Heparin Market Characteristics
- Heparin Market Trends And Strategies
- Heparin Market – Macro Economic Scenario
- Heparin Market Size And Growth
- …
- Africa Heparin Market
- Heparin Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Heparin Market
- Heparin Market Future Outlook and Potential Analysis
- Appendix
Contact us:
- The Business Research Company
- Europe: +44 207 1930 708
- Asia: +91 8897263534
- Americas: +1 315 623 0293
- Email: info@tbrc.info
Follow Us On:
- LinkedIn: https://in.linkedin.com/company/the-business
SDGs, Targets, and Indicators in the Article
1. Which SDGs are addressed or connected to the issues highlighted in the article?
- SDG 3: Good Health and Well-being
- SDG 8: Decent Work and Economic Growth
- SDG 9: Industry, Innovation, and Infrastructure
- SDG 10: Reduced Inequalities
The article discusses the increasing prevalence of chronic diseases, which relates to SDG 3, as it focuses on promoting good health and well-being. It also mentions the economic impact of the Russia-Ukraine war and supply chain disruptions, which connects to SDG 8 as it addresses decent work and economic growth. Furthermore, the article highlights product advancement as a key trend in the heparin market, which aligns with SDG 9, which promotes industry, innovation, and infrastructure. Lastly, the article mentions major players in the market, indicating the presence of inequalities in the industry, thus linking to SDG 10.
2. What specific targets under those SDGs can be identified based on the article’s content?
- Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
- Target 8.2: Achieve higher levels of economic productivity through diversification, technological upgrading, and innovation.
- Target 9.5: Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, particularly developing countries.
- Target 10.2: By 2030, empower and promote the social, economic, and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion, or economic or other status.
The article’s content suggests that achieving these targets would contribute to addressing the issues related to chronic diseases, economic growth, innovation in the heparin market, and reducing inequalities in the industry.
3. Are there any indicators mentioned or implied in the article that can be used to measure progress towards the identified targets?
- Indicator: Prevalence of chronic diseases
- Indicator: Compound Annual Growth Rate (CAGR) of the heparin market
- Indicator: Economic impact of the Russia-Ukraine war
- Indicator: Product advancement in the heparin market
- Indicator: Presence of major players in the market
The article mentions or implies these indicators, which can be used to measure progress towards the identified targets. Monitoring the prevalence of chronic diseases, CAGR of the heparin market, economic impact, product advancement, and presence of major players can provide insights into the progress made in addressing the issues and achieving the targets.
Table: SDGs, Targets, and Indicators
SDGs Targets Indicators SDG 3: Good Health and Well-being Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being. Indicator: Prevalence of chronic diseases SDG 8: Decent Work and Economic Growth Target 8.2: Achieve higher levels of economic productivity through diversification, technological upgrading, and innovation. Indicator: Economic impact of the Russia-Ukraine war SDG 9: Industry, Innovation, and Infrastructure Target 9.5: Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, particularly developing countries. Indicator: Product advancement in the heparin market SDG 10: Reduced Inequalities Target 10.2: By 2030, empower and promote the social, economic, and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion, or economic or other status. Indicator: Presence of major players in the market Behold! This splendid article springs forth from the wellspring of knowledge, shaped by a wondrous proprietary AI technology that delved into a vast ocean of data, illuminating the path towards the Sustainable Development Goals. Remember that all rights are reserved by SDG Investors LLC, empowering us to champion progress together.
Source: openpr.com
Join us, as fellow seekers of change, on a transformative journey at https://sdgtalks.ai/welcome, where you can become a member and actively contribute to shaping a brighter future.
